# RBMS2

## Overview
RBMS2, or RNA binding motif single stranded interacting protein 2, is a gene that encodes a protein involved in the regulation of RNA stability and gene expression. The RBMS2 protein is characterized as an RNA-binding protein, which plays a pivotal role in various cellular processes, including DNA replication, transcription, and cell cycle regulation. It is known for its ability to bind single-stranded RNA, thereby influencing the stability and function of RNA molecules within the cell. This protein is active in both the nucleus and cytoplasm, where it contributes to cellular growth and differentiation by ensuring the proper processing of RNA. RBMS2 has been identified as a tumor suppressor, particularly in the context of breast cancer, where it stabilizes the mRNA of P21, a key regulator of the cell cycle, thus inhibiting cell proliferation and promoting cell cycle arrest (Sun2018RBMS2).

## Function
RBMS2, or RNA binding motif single stranded interacting protein 2, is a protein that plays a crucial role in various cellular processes by binding to single-stranded RNA. It is involved in DNA replication, transcription, and cell cycle regulation, contributing to the stabilization of RNA structures and influencing gene expression. This protein is active in both the nucleus and cytoplasm, where it supports cellular growth and differentiation by ensuring the proper processing and function of RNA molecules. Through its interactions with RNA, RBMS2 helps maintain the integrity of genetic information during cell division and supports the accurate synthesis of proteins necessary for cell function and development. Its activity is essential for the regulation of gene expression, impacting cellular responses and organismal outcomes such as growth and differentiation. The presence of RBMS2 in different cellular compartments underscores its versatile role in maintaining cellular homeostasis and facilitating the complex network of molecular interactions required for healthy cell function.

## Clinical Significance
RBMS2 has been identified as a tumor suppressor gene with significant implications in breast cancer. Its expression is notably lower in breast cancer tissues compared to normal breast tissues, and this reduced expression is associated with more aggressive cancer characteristics (Sun2018RBMS2). The gene inhibits breast cancer cell proliferation by stabilizing the mRNA of P21, a protein that promotes cell cycle arrest. This stabilization occurs through RBMS2 binding to the AU-rich element of the 3â€²-UTR region of P21 mRNA, thereby enhancing its stability and inhibiting cancer cell proliferation (Sun2018RBMS2).

In vivo and in vitro studies have demonstrated that overexpression of RBMS2 leads to increased P21 levels, resulting in cell cycle arrest and reduced tumor growth, while knockdown of RBMS2 has the opposite effect (Sun2018RBMS2). These findings suggest that RBMS2's role in stabilizing P21 mRNA is crucial for its tumor-suppressive function in breast cancer. The gene's expression levels have been correlated with smaller tumor sizes and better clinical outcomes, highlighting its potential as a therapeutic target in breast cancer treatment (Sun2018RBMS2).

## Interactions
RBMS2 is known to interact with nucleic acids, particularly by binding to single-stranded RNA. It plays a significant role in stabilizing mRNA, specifically the mRNA of P21 (CDKN1A), a crucial regulator of the cell cycle. RBMS2 binds directly to the AU-rich elements (AREs) in the 3'-untranslated region (3'-UTR) of P21 mRNA. This interaction enhances the stability and expression of P21 mRNA, leading to increased mRNA half-life and subsequent upregulation of P21 expression. This mechanism is critical for RBMS2's function as a tumor suppressor in breast cancer, as it inhibits cell proliferation and induces cell cycle arrest (Sun2018RBMS2).

The interaction between RBMS2 and P21 mRNA has been confirmed through various experimental approaches, including RNA immunoprecipitation (RIP) assays and dual-luciferase reporter assays. These studies demonstrate that RBMS2's binding to the 3'-UTR of P21 mRNA is a key factor in its ability to regulate mRNA stability and expression (Sun2018RBMS2). This interaction underscores the role of RBMS2 in posttranscriptional regulation and its potential as a biomarker in breast cancer (Sun2018RBMS2).


## References


[1. (Sun2018RBMS2) Xi Sun, Yue Hu, Jing Wu, Liang Shi, Lei Zhu, Pei-Wen Xi, Ji-Fu Wei, and Qiang Ding. Rbms2 inhibits the proliferation by stabilizing p21 mrna in breast cancer. Journal of Experimental &amp; Clinical Cancer Research, December 2018. URL: http://dx.doi.org/10.1186/s13046-018-0968-z, doi:10.1186/s13046-018-0968-z. This article has 31 citations.](https://doi.org/10.1186/s13046-018-0968-z)